Targeting Mitophagy in Alzheimer's Disease
Dona P W Jayatunga1, Eugene Hone1,2, Prashant Bharadwaj1,2
1Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.
Journal of Alzheimer'S Disease : JAD
|December 8, 2020
Summary
Mitophagy, the cell's process for removing damaged mitochondria, is crucial for preventing neurodegeneration in Alzheimer's disease (AD). Enhancing mitophagy may offer a therapeutic strategy for AD.
Area of Science:
- Cell Biology
- Neuroscience
- Biochemistry
Background:
- Mitochondria are vital for cellular functions, including energy production and signaling.
- Maintaining healthy mitochondria is essential for cell viability.
- Mitophagy, the selective removal of damaged mitochondria, preserves mitochondrial integrity and function.
Purpose of the Study:
- To review emerging concepts in mitophagy.
- To discuss the molecular regulation and detection of mitophagy.
- To explore mitophagy dysfunction in Alzheimer's disease (AD) and its therapeutic potential.
Main Methods:
- Literature review of mitophagy research.
- Analysis of molecular mechanisms regulating mitophagy.
- Examination of mitophagy detection methods.
- Review of studies on mitophagy in AD models and patients.
Main Results:
- Mitophagy is a key protective mechanism against cellular damage.
- Mitochondrial dysfunction and impaired mitophagy are implicated in aging and neurodegenerative diseases like AD.
- Targeting mitophagy pathways shows promise for AD therapeutics.
Conclusions:
- Mitophagy plays a critical role in maintaining cellular health and preventing neurodegeneration.
- Dysfunctional mitophagy contributes to the pathogenesis of Alzheimer's disease.
- Stimulating mitophagy presents a potential therapeutic avenue for AD treatment.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
593
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
593
01:46Electron Transport Chain: Complex I and II
17.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
17.3K
01:26Alzheimer's Disease: Overview
1.2K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.2K
01:27Autophagy
5.4K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.4K